Ta-Xi-San Suppresses Atopic Dermatitis Involved in Multitarget Mechanism Using Experimental and Network Pharmacology Analysis

Table 3

The pharmacodynamic targets of TXS for AD.

No.	Target	Betweenness centrality (BC)	Closeness centrality (CC)	Degree
1	PTGS2	0.12968939	0.48461538	41
2	PTGS1	0.03576985	0.38729508	27
3	HSP90AA1	0.02247622	0.36914063	21
4	ESR1	0.0193549	0.38259109	15
5	PRKACA	0.00849434	0.34615385	14
6	RXRA	0.00732045	0.32926829	14
7	NOS2	0.01528486	0.37951807	12
8	ADRB2	0.00526221	0.32363014	11
9	TNF	0.03753438	0.42376682	11
10	TOP2A	0.00637523	0.33392226	11